Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Cowling, Randy T ^a   Zhang, Xiaowei ^a   Reese, Vanessa C ^a,c   Iwata, Michikado ^a   Gurantz, Devorah ^a   Dillmann, Wolfgang H ^a   Greenberg, Barry H ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Heart; Interleukin 1 ; Messenger RNA; Nuclear factor B; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CYTOKINE; HETEROGENEOUS NUCLEAR RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LUCIFERASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CISTRON; COMPUTER ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; EXOPHTHALMOS; EXTRACELLULAR MATRIX; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HEART; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR UPREGULATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ANIMALS; FIBROBLASTS; GENE EXPRESSION REGULATION; INTERLEUKIN-1; MYOCARDIUM; NF-KAPPA B; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA SPLICING; RNA, MESSENGER; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 23944509715     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00088.2005     Document Type: Article

References (39)

1. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, and Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89: 151-163, 1994.
2. Burlew BS and Weber KT. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 18: 435-442, 2000.
3. Clauser E, Curnow KM, Davies E, Conchon S, Teutsch B, Vianello B, Monnot C, and Corvol P. Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol 134: 403-411, 1996.
4. Cowling RT, Gurantz D, Peng J, Dillmann WH, and Greenberg BH. Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta. J Biol Chem 277: 5719-5724, 2002.
5. 1) receptor gene structure and function. Clin Exp Pharmacol Physiol Suppl 3: S67-S73, 1996.
6. Curnow KM, Pascoe L, Davies E, White PC, Corvol P, and Clauser E. Alternatively spliced human type 1 angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms. Mol Endocrinol 9: 1250-1262, 1995.
7. De Carvalho FC, Sun Y, and Weber KT. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. J Lab Clin Med 129: 439-446, 1997.
8. Delany AM. Measuring transcription of metalloproteinase genes. Nuclear run-off assay vs. analysis of hnRNA Methods Mol Biol 151: 321-333, 2001.
9. Guo DF, Uno S, Ishihata A, Nakamura N, and Inagami T. Identification of a cis-acting glucocorticoid responsive element in the rat angiotensin II type 1A promoter. Circ Res 77: 249-257, 1995.
10. 1 density in the post-MI heart. J Mol Cell Cardiol 38: 505-515, 2005.
11. Gurantz D, Cowling RT, Villarreal FJ, and Greenberg BH. Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts. Circ Res 85: 272-279, 1999.
12. Gyurko R, Kimura B, Kurian P, Crews FT, and Phillips MI. Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices. Biochem Biophys Res Commun 186: 285-292, 1992.
13. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, and Kolchanov NA. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367, 1998.
14. Herman JP, Schafer MK, Watson SJ, and Sherman TG. In situ hybridization analysis of arginine vasopressin gene transcription using intron-specific probes. Mol Endocrinol 5: 1447-1456, 1991.
15. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Van A, Dawood F, Wen WH, Shou Z, and Liu P. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99: 1492-1498, 1999.
16. Ji H, Zhang Y, Zheng W, Wu Z, Lee S, and Sandberg K. Translational regulation of angiotensin type 1a receptor expression and signaling by upstream AUGs in the 5′ leader sequence. J Biol Chem 279: 45322-45328, 2004.
17. Lee AA, Dillmann WH, McCulloch AD, and Villarreal FJ. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27: 2347-2357, 1995.
18. Lefroy DC, Wharton J, Crake T, Knock GA, Rutherford RA, Suzuki T, Morgan K, Polak JM, and Poole-Wilson PA. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol 28: 429-440, 1996.
19. Martin MM, Willardson BM, Burton GF, White CR, McLaughlin JN, Bray SM, Ogilvie JW Jr, and Elton TS. Human angiotensin II type 1 receptor isoforms encoded by messenger RNA splice variants are functionally distinct. Mol Endocrinol 15: 281-293, 2001.
20. Milavetz JJ, Raya TE, Johnson CS, Morkin E, and Goldman S. Survival after myocardial infarction in rats: captopril versus losartan. J Am Coll Cardiol 27: 714-719, 1996.
21. Murasawa S, Matsubara H, Urakami M, and Inada M. Regulatory elements that mediate expression of the gene for the angiotensin II type 1a receptor for the rat. J Biol Chem 268: 26996-27003, 1993.
22. Murphy TJ, Alexander RW, Griendling KK, Runge MS, and Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233-236, 1991.
23. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667, 1995.
24. Nogues G, Kadener S, Cramer P, Bentley D, and Kornblihtt AR. Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem 277: 43110-43114, 2002.
25. Ohtani S, Fujiwara H, Hasegawa K, Doyama K, Inada T, Tanaka M, Fujiwara T, and Sasayama S. Up-regulated expression of angiotensin II type 1 receptor gene in human pathologic hearts. J Card Fail 3: 303-310, 1997.
26. Ono K, Matsumori A, Shioi T, Furukawa Y, and Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98: 149-156, 1998.
27. 1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. Circ Res 91: 1119-1126, 2002.
28. Pfeffer JM, Pfeffer MA, and Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57: 84-95, 1985.
29. Rodrigues EJ, Eisenberg MJ, and Pilote L. Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction. Am J Med 115: 473-479, 2003.
30. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, and Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245-1254, 1993.
31. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, and Collins T. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19: 6367-6378, 1999.
32. Siwik DA, Chang DL, and Colucci WS. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86: 1259-1265, 2000.
33. Sun Y, Ramires FJ, and Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 35: 138-147, 1997.
34. 1a angiotensin receptor gene. Circ Res 73: 612-621, 1993.
35. Villarreal FJ, Kim NN, Ungab GD, Printz MP, and Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861, 1993.
36. West MJ, Lowe AD, and Karn J. Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation. J Virol 75: 8524-8537, 2001.
37. Wollert KC, Studer R, von Bulow B, and Drexler H. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition. Circulation 90: 2457-2467, 1994.
38. Yamagishi H, Kim S, Nishikimi T, Takeuchi K, and Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 25: 1369-1380, 1993.
39. Zhang Y, Ji H, Elena FM, Falconetti C, Zheng W, and Sandberg K. Translational control of the rat angiotensin type 1a receptor by alternative splicing. Gene 341: 93-100, 2004.